(Press-News.org) Min Li, Ph.D., a George Lynn Cross Professor of Medicine, Surgery and Cell Biology at the University of Oklahoma College of Medicine and Associate Director for Global Oncology at OU Health Stephenson Cancer Center, will receive the 2024 Palade Prize from the International Association of Pancreatology.
The Palade Prize, the IAP’s most distinguished award for research excellence, recognizes Li’s contributions to the field of pancreatology, which is dedicated to discovering new methods of identifying, diagnosing and treating diseases of the pancreas such as pancreatic cancer. The award is named after George E. Palade, who won the Nobel Prize in 1974 for his pioneering work involving a specialized pancreatic cell type. Li will receive the prize during the IAP annual meeting Dec. 9-12, and he will give a lecture on cancer cachexia and metabolic reprogramming.
Li has been continuously funded by the National Cancer Institute, a component of the National Institutes of Health, for the past 15 years, including three active R01 grants. His contributions to science focus on three areas:
Development of a combination therapy for pancreatic cancer using a novel surgical mouse model. As part of this work, his laboratory was the first to discover the role of a zinc transporter called ZIP4 in both pancreatic cancer and cachexia, a muscle-wasting condition that often occurs in tandem with pancreatic cancer.
Metabolic reprogramming and muscle wasting in pancreatic cancer. In this area, Li searches for a method of controlling the rapid weight loss of cachexia, which has no treatment. He is currently focused on the role of several enzymes and growth factors in the progression of cachexia.
Immunotherapy of pancreatic cancer. Because most immunotherapy drugs alone are not effective against pancreatic cancer, Li’s team developed a phototherapy/immunotherapy combination treatment that has been highly effective in mice with metastatic pancreatic cancer.
Li has published 216 articles in high-impact peer-reviewed journals and has given presentations on his research around the world. He has also mentored more than 30 graduate students and postdoctoral fellows, who have gone on to research careers in academia and industry, as well as junior faculty members who are beginning their careers.
Li is immediate past president of the American Pancreatic Association and is a standing member of the NIH Developmental Therapeutics study section and an ad hoc member of many other NIH study sections. He is editor-in-chief for the journal Cancer Letters and is an editorial board member for several other prestigious journals, including Clinical Cancer Research and BMC Medicine. He is also a member of the American Association for Cancer Research and the Association for Academic Surgeons.
He holds several other titles at OU Health Sciences, including Assistant Dean for International Research Collaboration in the OU College of Medicine; Vice Chairman for Research in the Department of Medicine and Department of Surgery, OU College of Medicine; and co-leader of the Cancer Biology Program at OU Health Stephenson Cancer Center. He also holds the Virginia Kerley Cade Endowed Chair in Cancer Treatment.
END
OU College of Medicine professor earns prestigious pancreatology award
2024-11-26
ELSE PRESS RELEASES FROM THIS DATE:
Sub-Saharan Africa leads global HIV decline: Progress made but UNAIDS 2030 goals hang in balance, new IHME study finds
2024-11-26
**Embargo: 23.30 [UK time], 6:30 p.m. [ET], 3:30 p.m. [PT], Monday, November 25 2024**
In contrast, the percentage of the population without a suppressed level of HIV (PUV) increased by 116.1% in Central Europe, Eastern Europe, and Central Asia from 2003 to 2021.
The study authors are issuing recommendations to invigorate the global HIV response across global public health programs dedicated to HIV control and expansion of prevention services.
The Institute for Health Metrics and Evaluation (IHME) has published a new study in The Lancet HIV journal that revealed significant progress in the global fight against HIV/AIDS, alongside ...
Popular diabetes and obesity drugs also protect kidneys, study shows
2024-11-26
The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes.1 Findings were published today in The Lancet Diabetes & Endocrinology.
Originally developed to treat diabetes, GLP-1 receptor agonists mimic the action of a hormone called glucagon-like peptide 1, which stimulates insulin production and lowers blood sugar levels. More recently, they have emerged as effective treatments for obesity - slowing digestion, ...
Stevens INI receives funding to expand research on the neural underpinnings of bipolar disorder
2024-11-25
Leila Nabulsi, PhD, a postdoctoral researcher in computational neuroscience at the Keck School of Medicine of USC’s Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) has received funding to expand research on the neurocircuitry that underlies bipolar disorder. Nabulsi was awarded the prestigious 2025 NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation, a highly competitive grant that provides early-career researchers with crucial pilot funding to pursue new avenues in ...
Protecting nature can safeguard cities from floods
2024-11-25
A new UBC-led study shows that safeguarding key natural ecosystems across Canada can help reduce flood risks for more than half of the country’s urban areas at high risk for flooding.
The research reveals that preserving the most important five per cent of watersheds—about 201,000 square kilometres or two per cent of Canada’s land—can significantly reduce rainwater runoff, protect homes and livelihoods, and safeguard croplands.
“This is the first national study to assess the role of Canadian ecosystems in flood prevention and to identify where conservation could have the greatest impact,” said Dr. Matthew ...
NCSA receives honors in 2024 HPCwire Readers’ and Editors’ Choice Awards
2024-11-25
The National Center for Supercomputing Applications was recognized by the HPCwire Readers’ and Editors’ Choice Awards for its outstanding achievements in artificial intelligence and the use of high-performance computing in the physical sciences.
Announced at Supercomputing Conference 2024 (SC24) in Atlanta on November 18, NCSA was awarded the Readers’ Choice Award: Best HPC Collaboration and Editors’ Choice: Best Use of HPC in Physical Sciences. It’s the 14th consecutive ...
Warning: Don’t miss Thanksgiving dinner, it’s more meaningful than you think
2024-11-25
Book the flight home for Thanksgiving, go to that party even though you’re tired, and write that thank you note. You may feel these experiences are not that significant in your busy life today, but according to Erin Westgate, assistant professor of psychology at the University of Florida, you are likely wrong.
Westgate and her team of researchers at the Florida Social Cognition and Emotion Lab recently received a grant from the National Science Foundation to investigate the factors that lead people ...
Expanding HPV vaccination to all adults aged 27-45 years unlikely to be cost-effective or efficient for HPV-related cancer prevention
2024-11-25
Embargoed for release until 5:00 p.m. ET on Monday 25 November 2024
@Annalsofim
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf ...
Trauma care and mental health interventions training help family physicians prepare for times of war
2024-11-25
Special Report
Background and Goal: In wars and conflict, family physicians are frequently called on to serve in expanded roles and are witnesses to the enormous mental and physical suffering of individuals, families, communities, and populations. This special report examines the role of family physicians in the Israel–Hamas conflict and other current wars to inform future practices in family medicine.
Key Insights: Family physicians must share timely, accurate information with colleagues on all sides of the conflict while acknowledging the narratives ...
Adapted nominal group technique effectively builds consensus on health care priorities for older adults
2024-11-25
Background and Goal: The participatory research approach is an important tool of family medicine and primary health care research. However, standard consensus methods like the Delphi and nominal group techniques can be time consuming and may not represent a broad range of opinions. To address these issues, researchers developed an adapted nominal group technique (aNGT) to efficiently build consensus among stakeholders with diverse perspectives.
Approach: This study focused on shaping care trajectories for adults aged 65 and older, aiming to prioritize key domains and identify new care indicators. Researchers used ...
Single-visit first-trimester care with point-of-care ultrasound cuts emergency visits by 81% for non-miscarrying patients
2024-11-25
The Bethesda Family Medicine Clinic in St. Paul, Minnesota, established a bi-monthly Early Pregnancy Dating & Risk Assessment Clinic in September 2022. The clinic introduced an integrated approach, combining point-of-care ultrasound with immediate, multidisciplinary first-trimester care. This integration allowed the clinic to quickly identify high-risk cases and offer timely intervention for issues such as miscarriage or abnormal pregnancies, reducing emergency visits, urgent clinic appointments, and first-trimester phone inquiries by 81% for non-miscarrying patients. Clinic implementation ...